E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 9/4/2014 in the Prospect News Structured Products Daily.

JPMorgan plans autocallable contingent interest notes on Valeant

By Marisa Wong

Madison, Wis., Sept. 4 – JPMorgan Chase & Co. plans to price autocallable contingent interest notes due Sept. 23, 2015 linked to the common stock of Valeant Pharmaceuticals International, Inc., according to an FWP filing with the Securities and Exchange Commission.

Each quarter, the notes will pay a contingent coupon at an annual rate of 16.25% if Valeant Pharmaceuticals shares close at or above the trigger price, 75% of the initial share price, on the review date for that quarter.

The notes will be automatically called at par plus the contingent coupon if Valeant Pharmaceuticals shares close at or above the initial share price on Dec. 18, March 19, 2015 or June 18, 2015.

If the notes have not been called, the payout at maturity will be par plus the final coupon unless the final share price is less than the trigger price, in which case investors will lose 1% for every 1% that the final share price is less than the initial share price.

J.P. Morgan Securities LLC is the agent.

The notes will price on Sept. 5 and settle on Sept. 10.

The Cusip number is 48127DZH4.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.